510(k) Report

510(k) · Cleared

Cleared

GalaFORM 3D

K162922510(k) TraditionalCleared Feb 23, 2017128-day reviewClass II21 CFR 878.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tepha, Inc. · OOD Surgical Film

Cleared on Feb 23, 2017 as substantially equivalent to K161092 (Tepha, Inc., 2016) and 1 other predicate after a 128-day review. Its family tree reaches back 13 generations to 1992.

Decided
Feb 23, 2017
Review
128 days
Class
Class II
Product code
OOD
Recalls
None
Predicates
2

Its longest line of descent runs back 13 generations to K921895 (1992). 62 ancestors in all, the oldest K810428 (1981). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2012: 1 other ancestor2011: 1 other ancestor2010: 1 other ancestor2007: 2 other ancestors2008: 1 other ancestor2005: 1 other ancestor2003: 4 other ancestors1985: 2 other ancestors1981: 1 other ancestor2004: 3 other ancestors2001: 4 other ancestors2006: 1 other ancestor2002: 2 other ancestors2000: 6 other ancestors1998: 6 other ancestors1997: 3 other ancestors1996: 3 other ancestors1983: 1 other ancestor1992: 1 other ancestor1991: 3 other ancestors1993: 1 other ancestor1988: 1 other ancestorK921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K980431 · Surgisis · Cook Biotech, Inc. · 1998K992159 · Surgisis Sling · Cook Biotech, Inc. · 1999K001738 · Depuy Restore Orthobiologic Soft Tissue Implant · DePuy Orthopaedics, Inc. · 2000K020049 · Fortaflex Surgical Mesh · Organogenesis, Inc. · 2002K042809 · Cuffpatch · Organogenesis, Inc. · 2004K051766 · Orthomend · Tei Biosciences, Inc. · 2005K071807 · Orthomend Soft Tissue Matrix · Tei Biosciences, Inc. · 2007 · recalledK083898 · Surgimend · Tei Biosciences, Inc. · 2009 · recalledK123128 · Seri Surgical Scaffold · Allergan · 2013K140533 · Galaflex Mesh · Tepha, Inc. · 2014K161092 · GalaSHAPE 3D · Tepha, Inc. · 2016 · recalled1980199020002010
  1. Root · 13 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 9 generations between
  3. 3 generations backK123128 Seri Surgical ScaffoldAllergan · 2013
  4. 2 generations backK140533 Galaflex MeshTepha, Inc. · 2014
  5. 1 generation backK161092 GalaSHAPE 3DTepha, Inc. · 2016 · Recalled
  6. This deviceK162922 GalaFORM 3DTepha, Inc. · 2017
Show all 13 generations
  1. Root · 13 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 12 generations backK961810 Supple Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 11 generations backK980431 SurgisisCook Biotech, Inc. · 1998
  4. 10 generations backK992159 Surgisis SlingCook Biotech, Inc. · 1999
  5. 9 generations backK001738 Depuy Restore Orthobiologic Soft Tissue ImplantDePuy Orthopaedics, Inc. · 2000
  6. 8 generations backK020049 Fortaflex Surgical MeshOrganogenesis, Inc. · 2002
  7. 7 generations backK042809 CuffpatchOrganogenesis, Inc. · 2004
  8. 6 generations backK051766 OrthomendTei Biosciences, Inc. · 2005
  9. 5 generations backK071807 Orthomend Soft Tissue MatrixTei Biosciences, Inc. · 2007 · Recalled
  10. 4 generations backK083898 SurgimendTei Biosciences, Inc. · 2009 · Recalled
  11. 3 generations backK123128 Seri Surgical ScaffoldAllergan · 2013
  12. 2 generations backK140533 Galaflex MeshTepha, Inc. · 2014
  13. 1 generation backK161092 GalaSHAPE 3DTepha, Inc. · 2016 · Recalled
  14. This deviceK162922 GalaFORM 3DTepha, Inc. · 2017
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−13K921895Tissue Patch, Tissue GraftBio-Vascular, Inc.1992—
−12K961810Supple Peri-Guard PericardiumBio-Vascular, Inc.1996—
−11K980431SurgisisCook Biotech, Inc.1998—
−10K992159Surgisis SlingCook Biotech, Inc.1999—
−9K001738Depuy Restore Orthobiologic Soft Tissue ImplantDePuy Orthopaedics, Inc.2000—
−8K020049Fortaflex Surgical MeshOrganogenesis, Inc.2002—
−7K042809CuffpatchOrganogenesis, Inc.2004—
−6K051766OrthomendTei Biosciences, Inc.2005—
−5K071807Orthomend Soft Tissue MatrixTei Biosciences, Inc.20074
−4K083898SurgimendTei Biosciences, Inc.20093
−3K123128Seri Surgical ScaffoldAllergan2013—
−2K140533Galaflex MeshTepha, Inc.2014—
−1K161092GalaSHAPE 3DTepha, Inc.20161
0 (this device)K162922GalaFORM 3DTepha, Inc.2017—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198110
198310
198520
198810
199130
199210
199310
199630
199730
199860
200060
200140
200220
200340
200430
200510
200610
200720
200810
201010
201110
201210
FIG. 1 — Lineage of K162922, 1992–2017Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OOD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OOD device

  1. #1 K233999 GalaFLEX LITE Scaffoldscore 7.1 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K161092GalaSHAPE 3D
Summary page 4
…ASSIFICATION REG/PANEL: CFR §878.3300 / General and Plastic Surgery PROCODE: OOD PREDICATE DEVICES: K161092 GalaSHAPE™ scaffold K140533 GalaFLEX® scaffold DEVICE DESCRIPTION: GalaFORM 3D scaffold is a bioresorbable surgical mesh manuf…
Tepha, Inc.20161
*K140533Galaflex Mesh
Summary page 4
…CFR §878.3300 / General and Plastic Surgery PROCODE: OOD PREDICATE DEVICES: K161092 GalaSHAPE™ scaffold K140533 GalaFLEX® scaffold DEVICE DESCRIPTION: GalaFORM 3D scaffold is a bioresorbable surgical mesh manufactured from poly-4- hydroxy…
Tepha, Inc.2014—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 7 companies; a new generation was cleared every 1.5 years on median.
  • 5 of the 62 ancestors have a recall of any class.

How does its category compare?

All OOD devices

OOD Surgical Film: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · OOD

1in 2024

2007: 12009: 12011: 12012: 22013: 12014: 12015: 12016: 22017: 12021: 12024: 1
2007high 2 (2012) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OOD

Too few OOD 510(k)s in any year since 2007 to give a median.

Recalls per year · OOD

1in 2016

2016: 1
2007high 1 (2016) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OOD

111in 2025

2012: 12013: 12014: 22015: 42016: 92017: 332018: 232019: 172020: 712021: 982022: 4302023: 1262024: 1962025: 111
2007high 430 (2022) · low 0 (2007)2025

MAUDE reports naming product code OOD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20091—00
20100—00
20111—00
20122—01
20131—01
20141—02
20151—04
20162—19
20171—033
20180—023
20190—017
20200—071
20211—098
20220—0430
20230—0126
20241—0196
20250—0111
20260—0—

What is it indicated for?

GalaFORM 3D scaffold is indicated for use as a bioresorbable scaffold for soft tissue support and to repair, elevate and reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome. This includes reinforcement of soft tissue in plastic and reconstructive surgery, and general soft tissue reconstruction. GalaFORM 3D scaffold is also indicated for the repair of fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K162922: GalaFORM 3D.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K162922

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026